ResearcherTokyo Metropolitan Tama Medical CenterActive in the last 2 years
Yasuhiro Morita
Matched on ORCID iD 0000-0002-0205-5289; OpenAlex author ID A5039946018. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 6
2026: 2 papers
Papers 2
- Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case Report. Last author DOI 10.70352/scrj.cr.25-0670↗
- Exceptional Long-Term Survival after Resection of Metachronous Liver and Lung Metastases Following Surgery for Pancreatic Cancer: A Case Report. Last author DOI 10.70352/scrj.cr.26-0115↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Taiki Tsuji · 2 shared papers, 2026 · strength 0.49
- Paper Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case… DOI 10.70352/scrj.cr.25-0670↗
- Paper Exceptional Long-Term Survival after Resection of Metachronous Liver and Lung Metastases Following Surgery for Pancreat… DOI 10.70352/scrj.cr.26-0115↗
- Taku Higashihara · 2 shared papers, 2026 · strength 0.49
- Paper Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case… DOI 10.70352/scrj.cr.25-0670↗
- Paper Exceptional Long-Term Survival after Resection of Metachronous Liver and Lung Metastases Following Surgery for Pancreat… DOI 10.70352/scrj.cr.26-0115↗
- Makoto Takahashi · 2 shared papers, 2026 · strength 0.49
- Paper Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case… DOI 10.70352/scrj.cr.25-0670↗
- Paper Exceptional Long-Term Survival after Resection of Metachronous Liver and Lung Metastases Following Surgery for Pancreat… DOI 10.70352/scrj.cr.26-0115↗
- Ryohei Horie · 1 shared paper, 2026 · strength 0.25
- Takumi Miwa · 1 shared paper, 2026 · strength 0.24
- Dai Inoue · 1 shared paper, 2026 · strength 0.24
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.